PositronPharma

Providencia, Chile Founded: 2010 • Age: 16 yrs
Produces and supplies radiopharmaceuticals for PET imaging and cancer detection in Chile.

About PositronPharma

PositronPharma is a company based in Providencia (Chile) founded in 2010. It operates as a B2B. PositronPharma offers products and services including 18F, 68GaDOTATATE, and 68GaPSMA. PositronPharma operates in a competitive market with competitors including Curasight, MedTrace, Fuzionaire Theranostics, Positron Precision and Laboratorios Bacon, among others.

  • Headquarter Providencia, Chile
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Medical Devices & Diagnostics
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of PositronPharma

PositronPharma offers a comprehensive portfolio of products and services, including 18F, 68GaDOTATATE, and 68GaPSMA. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Used for marking compounds in cancer detection via PET imaging.

Targets neuroendocrine tumors for diagnostic imaging purposes.

Detects prostate cancer cells through specific antigen marking.

Funding Insights of PositronPharma

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by PositronPharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - PositronPharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Positronpharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of PositronPharma

PositronPharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Curasight, MedTrace, Fuzionaire Theranostics, Positron Precision and Laboratorios Bacon, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
uPAR-based PET ligands for breast cancer imaging are developed.
domain founded_year HQ Location
Molecular imaging solutions for cardiac PET are provided by MedTrace.
domain founded_year HQ Location
Develops theranostics platform for cancer diagnostics and therapies via innovative chemistry.
domain founded_year HQ Location
Develops innovative radiopharmaceutical technologies for positron emission tomography.
domain founded_year HQ Location
Offers medical products for diagnosis, treatment, and testing in healthcare sectors.
domain founded_year HQ Location
Develops PET-based technology to visualize and measure pain for better management.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Positronpharma

Frequently Asked Questions about PositronPharma

When was PositronPharma founded?

PositronPharma was founded in 2010.

Where is PositronPharma located?

PositronPharma is headquartered in Providencia, Chile. It is registered at Providencia, Santiago Metropolitan Region, Chile.

What does PositronPharma do?

PositronPharma specializes in manufacturing and delivering radiopharmaceuticals for diagnostic purposes, primarily using PET imaging technology. They operate from Santiago, Chile, with a cyclotron and automated radiosynthesis modules to ensure high precision and safety. The company focuses on products like 18F for various cancer studies and serves medical institutions nationwide. They prioritize quality control and efficient national distribution to support healthcare providers in detecting tumors and neuroendocrine conditions.

Who are the top competitors of PositronPharma?

PositronPharma's top competitors include Curasight, MedTrace and Molecular Theranostics.

What products or services does PositronPharma offer?

PositronPharma offers 18F, 68GaDOTATATE, and 68GaPSMA.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available